Cite
A 3′ tRNA‐derived fragment produced by tRNALeuAAG and tRNALeuTAG is associated with poor prognosis in B‐cell chronic lymphocytic leukemia, independently of classical prognostic factors.
MLA
Katsaraki, Katerina, et al. “A 3′ TRNA‐derived Fragment Produced by TRNALeuAAG and TRNALeuTAG Is Associated with Poor Prognosis in B‐cell Chronic Lymphocytic Leukemia, Independently of Classical Prognostic Factors.” European Journal of Haematology, vol. 106, no. 6, June 2021, pp. 821–30. EBSCOhost, https://doi.org/10.1111/ejh.13613.
APA
Katsaraki, K., Adamopoulos, P. G., Papageorgiou, S. G., Pappa, V., Scorilas, A., & Kontos, C. K. (2021). A 3′ tRNA‐derived fragment produced by tRNALeuAAG and tRNALeuTAG is associated with poor prognosis in B‐cell chronic lymphocytic leukemia, independently of classical prognostic factors. European Journal of Haematology, 106(6), 821–830. https://doi.org/10.1111/ejh.13613
Chicago
Katsaraki, Katerina, Panagiotis G. Adamopoulos, Sotirios G. Papageorgiou, Vasiliki Pappa, Andreas Scorilas, and Christos K. Kontos. 2021. “A 3′ TRNA‐derived Fragment Produced by TRNALeuAAG and TRNALeuTAG Is Associated with Poor Prognosis in B‐cell Chronic Lymphocytic Leukemia, Independently of Classical Prognostic Factors.” European Journal of Haematology 106 (6): 821–30. doi:10.1111/ejh.13613.